Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
05/2004
05/06/2004US20040087020 Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin
05/06/2004US20040087014 Eukaryotic expression libraries and methods of use
05/06/2004US20040087004 Process for producing a culture of antrodia camphorata and product obtained thereby
05/06/2004US20040087003 Methods and cells for improved production of polyketides
05/06/2004US20040087001 Transgenic viral particles to enhance cell fusion and transfer genetic material into polymorphonuclear leukocytes (PMNL); gene therapy
05/06/2004US20040087000 Isopenicillin N synthetase and deacetoxycephalosporin C synthetase enzymes and method
05/06/2004US20040086998 Comprises nucleotide sequences coding regulatory elements and protein with trehalose-6-phosphate synthase activity for transformation and expression in yeast; heterologous gene expression and bioreactors
05/06/2004US20040086993 Alpha-keto acid reductase, method for producing the same, and method for producing optically active alpha-hydroxy acids using the same
05/06/2004US20040086990 Using transgenic saccharomyces to ferment monosodium glutamate; taste and flavor enhancement
05/06/2004US20040086989 Increase in the vitamin e content in organisms due to an increase in the tyrosine aminotransferase activity
05/06/2004US20040086986 Process for producing acrylamide using a microbial catalyst having been wahed with aqueous acrylic acid solution
05/06/2004US20040086985 Methods of producing agmatine and arginine decarboxylace
05/06/2004US20040086984 Microbiological method for producing ascorbic acid
05/06/2004US20040086982 Using transgenic bacillus to ferment vitamin b5, valine and isoleucine
05/06/2004US20040086979 Preparing monoclonal antibody with reduced immunogenicity; diagnostic tools; immunotherapy
05/06/2004US20040086977 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
05/06/2004US20040086976 Genetically engineered erythropoietin for diagnosis, prevention and treatment of thrombis, cancer, neovascularization, inflammation and autoimmune diseases
05/06/2004US20040086974 Comprises human tumor suppressor protein for treatment and prevention of cell proliferative disorders; antitumor/anticarcinogenic/antiproliferative agents
05/06/2004US20040086973 Calmodulin-dependent protein kinase inhibitor for treatment and prevention of nervous system disorders
05/06/2004US20040086972 Directed evolution of microorganisms
05/06/2004US20040086971 Comprises nucleotide sequences coding extracellular matrix protein for prevention and treatment of inflammatory, immune and thrombotic disorders
05/06/2004US20040086969 Expressing heterologous polypeptides in rhodospirillum; bioreactors; vaccine development
05/06/2004US20040086968 Mutants of green fluorescent protein
05/06/2004US20040086965 Casein peptide fragments with growth-influencing activity on cell cultures
05/06/2004US20040086962 Methods and materials relating to gene expression
05/06/2004US20040086961 Amino acid modified polypeptides
05/06/2004US20040086960 Transgenic cell expressing human leukocyte antigen fusion proteins for induction of cytotoxic T cell responses against viral and tumor antigens; immunotherapy
05/06/2004US20040086955 Metabolically engineered lactic acid bacteria and their use
05/06/2004US20040086940 Novel g protein-coupled receptor protein and dna thereof
05/06/2004US20040086923 Comprises polypeptide with carbamoyl phosphate synthase (CPS) activity for identifying modulators which prevent and/or treat cancer and metabolic disorders
05/06/2004US20040086913 Human genes and gene expression products XVI
05/06/2004US20040086905 Lipid-associated molecules
05/06/2004US20040086900 Generating transgenic yeast coding heterologous phosphodiesterase for identifying modulators for treatment of cardiovascular, asthma, depression and thrombotic disorders
05/06/2004US20040086899 Compromises nuclelotide sequences coding polypeptides associated with elongation of fatty acid chains for treatment and prevention of skin, cardiovascular, inflammatory, gastrointestinal, respiratory system and bone disorders
05/06/2004US20040086898 Comprises nucleotide sequences coding g protein coupled receptor for identifying modulator for treatment and prevention of cardiovascular, respiratory, muscle, liver, gastrointestinal, urogenital and blood disorders
05/06/2004US20040086890 DNA polymerases with reduced base analog detection activity
05/06/2004US20040086886 Identifying allelic modifications in ion transport proteins which cause drug induced long qt symdrome; diagnosing and prognosing cardiovascular disorders
05/06/2004US20040086877 Multi-mode directi memory access controller and method
05/06/2004US20040086863 Comprises pleckstrin homology domain-interacting protein (PHI Protein) for identifying modulator and treatment for cancer and insulin response disorders
05/06/2004US20040086859 Identification of a dual specificity phosphate: dusp-10
05/06/2004US20040086858 Identification of new human gaba transporter
05/06/2004US20040086846 Using bacterial artificial chromosomes to propagate/replicate viral nucleotide sequences; gene therapy and genetic vaccines
05/06/2004US20040086533 For inhibiting bacterial invasion via intestinal barrier containing live Bacillus subtilis cells as an active ingredient
05/06/2004US20040086530 Transgenic plant or plant cell that, when consumed as a foodstuff in four or less feedings, elicits an anti-HBsAg boosting immune response that increases serum anti-HBsAg antibody levels at least four-fold
05/06/2004US20040086525 Polynucleotide sequences of C. pneumoniae for use in preventing and treating Chlamydia infection
05/06/2004US20040086507 Antibody inhibiting vplf activity
05/06/2004US20040086503 High-affinity human anti-IGF-IR antibodies that could be used to treat diseases in humans
05/06/2004US20040086502 Has a binding affinity for a target antigen which is at least about two fold stronger than the binding affinity of the parent antibody for said antigen
05/06/2004US20040086500 Murabutide, an analog of muramyl dipeptide, induces the production of cytokines or other factors not identified to date, which have a suppressor activity on HIV
05/06/2004US20040084426 Microdissection apparatus and method
05/06/2004US20040084376 Method for direct clarification of groundwater polluted with nitrate
05/06/2004EP1416050A1 Method of modifying enzyme and oxidoreductase variant
05/06/2004EP1416045A1 Composition containing a fungal cellulase for the treatment of cotton-containing fabrics
05/06/2004EP1416043A1 Leguminous bacterium having potentiated nitrogen fixation ability
05/06/2004EP1415998A2 Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies
05/06/2004EP1415997A1 Polypeptides relating to signal transfer of advanced glycation end product receptor
05/06/2004EP1415996A2 Transformed cell with enhanced sensitivity to antifungal compound and use thereof
05/06/2004EP1415994A1 Retinal pigmented epithelium derived neurotrophic factor
05/06/2004EP1415656A1 Lactobacillus strains capable of preventing diarrhoea caused by rotaviruses
05/06/2004EP1414994A2 Microorganisms and cells for diagnosis and therapy of tumors
05/06/2004EP1414986A2 Coryneform bacteria which produce chemical compounds ii
05/06/2004EP1414985A2 Process for the fermentative preparation of l-amino acids using coryneform bacteria
05/06/2004EP1414979A1 Vector for site-specific integration of heterologous dna sequences into the rdna sites of methylotrophic yeasts
05/06/2004EP1414978A1 Novel recombinant gene expression method by stop codon suppression
05/06/2004EP1414971A2 Salutaridinol 7-o-acetyltransferase and derivatives thereof
05/06/2004EP1414970A2 Production of l-lysine by genetically modified corynebacterium glutamicum strains
05/06/2004EP1414969A2 Biosynthetic genes for butenyl-spinosyn insecticide production
05/06/2004EP1414967A2 Gene associated with leishmania parasite virulence
05/06/2004EP1414965A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/06/2004EP1414964A2 Vegf isoform
05/06/2004EP1414963A2 Lipid-associated molecules
05/06/2004EP1414962A1 Novel genetic products of ashbya gossypii, associated with the mechanisms of signal transduction and especially with the improvement of vitamin b2 production
05/06/2004EP1414952A2 Process for the fermentative preparation of l-amino acids using coryneform bacteria
05/06/2004EP1414950A2 Chimeric proteins comprising a haem domain of a mammalian or plant cytochrome p450 and a scaffold-reductase domain from p450 bm3 of bacillus megaterium and uses thereof
05/06/2004EP1414943A2 Lactic acid production
05/06/2004EP1414942A2 Expression of core-glycosylated hcv envelope proteins in yeast
05/06/2004EP1414941A2 Product and process for transformation of thraustochytriales microorganisms
05/06/2004EP1414940A2 Expression of functional human olfactory cyclic nucleotide gated (cng) channel in recombinant host cells and use thereof in cell based assays to identify smell modulators
05/06/2004EP1414861A2 Humanized antibodies against icam-1, their production and uses
05/06/2004EP1414858A2 Single chain camelid vhh antibodies, method for their production in a mammal, and their uses
05/06/2004EP1414844A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
05/06/2004EP1414838A2 Polypeptides having carotenoids isomerase catalytic activity, nucleic acids encoding same and uses thereof
05/06/2004EP1414477A2 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
05/06/2004EP1414471A2 Therapeutic agents comprising pro-apoptotic proteins
05/06/2004EP1414422A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
05/06/2004EP1341924B1 Method for producing biomass
05/06/2004EP1181027B1 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
05/06/2004EP1007647B1 High level of expression of ingap
05/06/2004EP0819173B1 Mutant of the erythrina caffra type inhibitor and the use of the said mutant for purifying serin proteases
05/06/2004DE10245993A1 Cells that produce enantiomerically enriched R-alpha-lipoic acid, useful e.g. as antioxidants for treating diabetes and its complications, and which over express the lipoyl-protein-ligase B gene
05/06/2004CA2503038A1 Dna polymerases with reduced base analog detection activity
05/06/2004CA2483574A1 Zymomonas pentose-sugar fermenting strains and uses thereof
05/06/2004CA2483550A1 Fagopyrum esculentum fagopyritol synthase gene and use thereof
05/06/2004CA2468903A1 Endogenous retrovirus up-regulated in prostate cancer
05/05/2004CN1494596A Method of preparing 2-deoxyribose 5-phosphate
05/05/2004CN1494591A Polynucleotide useful for modulating cancer cell proliferation
05/05/2004CN1494552A Flt 4 (VEGFR-3) as target for tumor imaging and anti-tumor therapy
05/05/2004CN1494426A Bacterial translocation inhibitor and method of inhibiting bacterial translocation
05/05/2004CN1494374A Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof
05/05/2004CN1493686A Reproduction expanding method of reed fermentation special microorganism